CVL237 not checked
Convalife (Shanghai) Co., Ltd.
FollowEvery change as it happens, and a Monday email
Trials
2 active
3 in total
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “CVL237 tablets, 200 mg, taken with food once daily for 28 consecutive days as a treatment cycle.”In the company’s words, NCT06183736 on ClinicalTrials.gov
- Tested for
- Advanced Solid Tumors, Locally Advanced or Metastatic Solid Tumors, PTEN Loss or Low Expression
- Main trialPhase 2
- “This is a single-arm, open-label, multicenter, phase II study of CVL237 tablets in the treatment of advanced solid tumors with PTEN deficiency. It is planned to enroll patients with PTEN deficiency advanced solid tumors of different tumor types (PTEN deficiency gastric cancer, prostate cancer, endometrial cancer, colorectal cancer, lung cancer, breast cancer and melanoma etc.) to evaluate the preliminary efficacy, safety and pharmacokinetic profile of CVL237 tablets in patients with PTEN deficiency advanced solid tumors of different tumor types.”In the company’s words, NCT06183736 on ClinicalTrials.gov
Other drugs for Advanced Solid Tumors
- AvelumabEMD Serono Research & Development Institute, Inc. · Phase 3
- AlectinibRoche · Phase 3
- AtezolizumabRoche · Phase 3
- AU-011Aura Biosciences · Phase 3
- BevacizumabRoche · Phase 3
- CadonilimabAkeso · Phase 3
Coming up1
- 9 Jan 2028Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Not yet recruiting | 30 Jun 2025 | CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency | |
| Phase 2Not yet recruiting | 9 Jan 2028 | A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression | |
| Phase 2/3Unknown | 29 Dec 2025 | CVL237 Tablets for APDS/PASLI |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026